NTNayuta Tsushima

Nayuta Tsushima

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Nayuta Tsushima has a total of 28 co-authors. Here are the top co-authors by number of shared publications:

  • Satoshi Kano

    Department of Otolaryngology-Head and Neck Surgery, Faculty of Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Japan

    5 shared publications
  • Takayoshi Suzuki

    Department of Otolaryngology-Head and Neck Surgery, Faculty of Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Japan

    4 shared publications
  • Akihiro Homma

    Department of Otolaryngology-Head & Neck Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Kita-Ku, N15W7, Sapporo 0608638, Hokkaido, Japan

    3 shared publications
  • Hiroshi Idogawa

    Department of Otolaryngology-Head and Neck Surgery, Faculty of Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Japan

    3 shared publications
  • Seijiro Hamada

    Department of Otolaryngology-Head and Neck Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan; Department of Otorhinolaryngology, Steel Memorial Muroran Hospital, Hokkaido, Japan

    3 shared publications
  • Akihiro Homma

    Department of Otolaryngology-Head and Neck Surgery, Faculty of Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Japan

    2 shared publications

Latest Publications

  • Resting heart rate as a prognostic indicator for patients with head and neck squamous cell carcinoma

    by Nayuta Tsushima, Satoshi Kano, Takayoshi Suzuki, Hiroshi Idogawa, Masaki Kakumu, Hayato Imanari, Akihiro Homma

    Background Elevated resting heart rate (RHR) has been associated with poor prognosis in various cancers, but its significance in head and neck cancer (HNC) remains unclear. This study aimed to evaluate the prognostic impact of RHR and its association with the incidence of second primary cancer (SPC). Methods We retrospectively analyzed 213 patients with oropharyngeal, hypopharyngeal, or laryngeal squamous cell carcinoma who underwent chemoradiotherapy. Pretreatment RHR was measured from electrocardiograms, and survival outcomes were analyzed using Kaplan-Meier and Cox regression models. Results Patients with an RHR ≥ 83 bpm had significantly worse overall survival (P = 0.004) and disease-specific survival (P < 0.001). Elevated RHR was an independent prognostic factor and was associated with an increased incidence of SPC (P = 0.016), particularly esophageal cancer (P = 0.003). In exploratory analyses, this association with esophageal SPC remained after adjustment for alcohol consumption category and smoking status. Conclusions RHR is a potential prognostic marker in HNC and, in exploratory analyses, was associated with an increased risk of SPCs, particularly esophageal cancer. These findings suggest that RHR may help stratify risk in patients with HNC, although further studies are needed to clarify its clinical implications.

  • Running pattern of the internal maxillary artery assessed using arterial-phase CT images in 434 sides in Japanese individuals

    by Nayuta Tsushima, Satoshi Kano, Takayoshi Suzuki, Seijiro Hamada, Hiroshi Idogawa, Ryohei Katsumata, Akihiro Homma

  • Targeted next-generation sequencing of Japanese patients with sinonasal mucosal melanomas identifies frequent NRAS and CTNNB1 mutations

    by Nayuta Tsushima, Satoshi Kano, Kanako C. Hatanaka, Takayoshi Suzuki, Seijiro Hamada, Hiroshi Idogawa, Yuji Nakamaru, Masanobu Suzuki, Yutaka Hatanaka, Akihiro Homma


  • Treatment outcomes of the patient with sinonasal mucosal melanoma: the role of endoscopic resection and postoperative radiotherapy

    by Nayuta Tsushima, Satoshi Kano, Koichi Yasuda, Takayoshi Suzuki, Seijiro Hamada, Yuji Nakamaru, Masanobu Suzuki, Yusuke Uchinami, Hidefumi Aoyama, Akihiro Homma

    Background The standard of care for sinonasal mucosal melanoma is surgery and postoperative radiotherapy (PORT). Our treatment strategy comprises endoscopic resection and PORT. We performed combined endoscopic and open resection or applied an external approach alone when sufficient resection was difficult to achieve endoscopically. The objective of this study was to evaluate the validity of our treatment strategy. Methods We assessed 30 patients with sinonasal mucosal melanoma who underwent definitive therapy between January 2002 and April 2021, and conducted a retrospective analysis. The median follow-up period was 2.2 years. The primary endpoint was overall survival. The Kaplan–Meier method was used for the calculation of survival rates, the cumulative incidence of distant metastasis, and local recurrence. Results Twenty-eight patients underwent surgery. The other two patients were treated by definitive proton beam therapy. Twenty-one of 28 (75%) patients underwent resection by endoscopic approach alone. Postoperative radiotherapy was performed for all 28 patients who underwent surgery. Twenty-one patients (70%) experienced recurrence during the observation period. Overall, distant metastasis was observed in 19 patients. Twelve patients died during the observation period, with 10 of the 12 patients (83%) dying of distant metastasis. The overall survival rate at 2 and 5 years was 70% and 46%, respectively. The cumulative incidence rate of distant metastasis at 2 years was 63%, while the 2-year cumulative incidence rate of local recurrence was 6.7%. Conclusion The local disease was controlled by our treatment strategy. To improve treatment outcomes, control of the distant metastasis is needed.


  • Open Access

    Salvage Reconstructive Surgery During Nivolumab Therapy for a Patient With Hypopharyngeal Cancer

    by Nayuta Tsushima, Takeshi Shinozaki, Takao Fujisawa, Toshifumi Tomioka, Wataru Okano, Masakazu Ikeda, Makoto Tahara, Takuya Higashino, Ryuichi Hayashi

    Objectives: Nivolumab, a fully IgG4-programmed death-1 inhibitor antibody, led to improved overall survival compared with single-agent therapy in patients with platinum-refractory recurrent head and neck cancers. In general, nivolumab is used in inoperable patients. To the best of our knowledge, there have been no reports of salvage surgery during nivolumab therapy for patients with head and neck cancer. We report the case of a woman treated with salvage reconstructive surgery during nivolumab therapy. Method: Case report and literature review. Results: The patient underwent nivolumab therapy for recurrent primary and neck disease after induction chemotherapy, followed by concurrent chemoradiation therapy. The neck disease shrunk, whereas the primary disease temporarily shrunk but later progressed again. Recurrent primary disease led to a narrowing of her airway, and she required airway management. We performed total pharyngolaryngectomy with free jejunal reconstruction, and her quality of life improved. The surgery was performed without complications and the postoperative course was uneventful. She was discharged postoperative day 18 with oral intake function and a safer airway. Conclusion: As far as we know, this is the first report of salvage surgery during nivolumab therapy for patients with head and neck cancer. The salvage reconstructive surgery in this case proceeded uneventfully.


  • The role of elective neck dissection for cT4aN0 glottic squamous cell carcinoma

    by Nayuta Tsushima, Ryuichi Hayashi, Takeshi Shinozaki, Toshifumi Tomioka, Wataru Okano, Masakazu Ikeda

    Objective The indication for elective neck dissection for patients with clinically T4aN0 (cT4aN0) glottic cancer is not established. The objective of this study was to evaluate the role of elective neck dissection for patients with cT4aN0 glottic cancer. Methods We assessed patients with cT4aN0 laryngeal squamous cell carcinoma who underwent total laryngectomy between 1998 and 2014 and conducted a retrospective analysis. We considered occult neck metastasis positive when confirmed by histological analysis. When patients with late neck metastases did not undergo therapeutic neck dissection, the presence of occult neck metastasis was judged on the basis of computed tomography. The validity of elective neck dissection for patients with cT4aN0 glottic cancer was assessed from comparisons the rates of occult neck metastases of supraglottic and subglottic cancers, which are generally recommended for elective neck dissection. The distribution of occult neck metastases in glottic cancer is described according to nodal levels. Results The rate of occult neck metastasis of cT4aN0 laryngeal cancer was 36% (14/39). There were no significant differences among the rates of glottic 7/21 (33%), supraglottic 3/8 (38%) and subglottic 4/10 (40%) cancers. Patients with glottic cancer did not have bilateral Level IIB and ipsilateral Level IV metastasis. One patient had contralateral Level IV metastasis. The metastases rates of ipsilateral Levels IIA, III, and VI were >10%. Conclusions We think that elective neck dissection is valid for cT4aN0 glottic cancer. Ipsilateral Levels IIA, III and VI should be dissected. The omission of neck dissection for bilateral Levels IIB and IV can be considered when there is a need to avoid complications.